The WordPress.com stats helper monkeys prepared a 2013 annual report for this blog.
Here’s an excerpt:
The concert hall at the Sydney Opera House holds 2,700 people. This blog was viewed about 32,000 times in 2013. If it were a concert at Sydney Opera House, it would take about 12 sold-out performances for that many people to see it.
The Minister of Science and Technology of South Africa, Derek Hanekom, launched the National Bioeconomy Strategy last Tuesday in Pretoria. The science-based Bioeconomy Strategy, approved by South African Cabinet in November last year, positions bio-innovation as essential to the achievement of government’s industrial and social development goals. The strategy calls for industry, science councils, government departments and academia to cooperate closely to ensure that biotechnology and bio-innovations are market relevant and find easier application in South Africa.
The results of a field trial with genetically modified poplar trees in Zwijnaarde, Belgium, led by VIB – a life sciences research institute in Flanders funded by the Flemish government – shows that the wood of lignin modified poplar trees can be converted into sugars in a more efficient way. These sugars can serve as the starting material for producing bio-based products like bio-plastics and bio-ethanol.
“Sustainable production and use of bioresources from agriculture and forestry have a long tradition in Austria and besides the use of wood for construction, composite materials and energy production, the use of renewables and organic waste for the production of fibres, paper, chemicals, biodiesel, food&feed and pharmaceuticals are crucial to internationally leading Austrian industries active in production and engineering”. To say it in this exclusive interview with us is Anton Glieder, associate professor at the Institute of Molecular Biotechnology of Graz University of Technology and Scientific Director, Ceo and Cso of the Austrian Centre of Industrial Biotechnology (ACIB GmbH). With Glieder we talk about industrial biotechnology and the role of Austria in the European bioeconomy.
Interview by Mario Bonaccorso
The US biotech company Amyris aims at becoming a great player in the world bioeconomy. Founded in 2003 in the San Francisco Bay Area by a group of scientists at the University of California, Berkeley, Amyris – as anticipated during its prior quarter results call – has begun the production of its first fragrance oil at a specialty contract manufacturing facility. In 2014, building on the successful results of its initial fragrance oil production and based on feedback from its partner, Amyris plans to also produce this fragrance oil at its own Brotas production facility. The Brotas biorefinery currently produces Biofene, Amyris’s brand of farnesene, a renewable hydrocarbon used for a range of applications. Following planned improvements to the Brotas plant in early 2014, Amyris expects to be able to produce both Biofene and a range of other fermentation products, including its fragrance oils, at the plant.
This announcement follows the one of last December, when Amyris announced together with the French oil giant Total the formation of Total Amyris Biosolutions, a 50-50 joint venture that will produce market renewable diesel and jet fuel.
Happy New Year to all. The just begun 2014 must be the year of economic growth and employment recovery. Especially for Old Europe. There are no alternatives. Meanwhile, the CEBR has told us about how it will change the economic geography of the world by 2030, reporting even unusual overtakings such as the United Kingdom, which is preparing to oust Germany from the throne of Europe. The latest research conducted by the Centre for Economics and Business Research (CEBR) ranks the world economies of “greater weight”.
Actinogen Limited, heaquartered in Western Australia, has entered into a collaborative and royalty agreement with Leaf Energy Ltd in the company’s Bioethanol project. Under the terms of the agreement Leaf Energy, an Australian company focused on turning waste into biofuels, bioplastics and green chemicals, will fund further studies in Actinogen’s Bioethanol project; in which the company previously identified strains of actinomycetes capable of producing cellulases. Cellulase are enzymes used to breakdown cellulose from plant material, papers and industrial waste glycerols (biomass), and are an important step in the production of second generation bioethanols.
BASF and Renmatix will jointly scale up the Renmatix Plantrose process for the production of industrial sugars based on lignocellulosic biomass. The two companies signed a non-exclusive joint development agreement. The parties have agreed to key financial terms for future commercial licenses, which BASF can exercise at its discretion. The collaboration follows BASF’s $30 million investment in Renmatix in January 2012.
VTT Technical Research Centre of Finland, the biggest multitechnological applied research organisation in Northern Europe, at the request of the South Australian State Government, studied the condition of the forest sector industries in the Green Triangle region and examined the added value that may be achievable through high technology production.
IL BIOECONOMISTA 